E26.81

Clinical Causes: Genetic mutations affecting the kidneys' electrolyte transport mechanisms. Inheritance patterns are usually autosomal recessive, meaning a person needs two copies of the mutated gene to develop the condition. Specific gene mutations include those in the SLC12A1, KCNJ1, ROMK, and BSND genes, which are vital for electrolyte transport in kidney tubules. Environmental factors do not directly cause Bartter’s syndrome but can influence symptom severity.

Key Symptoms: Muscle weakness or cramps due to electrolyte imbalance. Frequent thirst and excessive urination, often leading to dehydration. Low blood pressure, which may cause dizziness or fainting. Delayed growth and development in children. Fatigue and general weakness. Electrolyte disturbances visible in blood tests, such as low potassium (hypokalemia) and chloride levels. In some cases, symptoms may also include salt cravings and muscle fatigue.

Diagnosis Path: Blood tests to measure electrolyte levels, often revealing low potassium and chloride. Urinalysis to assess electrolyte excretion and kidney function. Genetic testing to identify specific gene mutations associated with Bartter’s syndrome. Measurement of blood pressure, which may be lower than normal in affected individuals. Additional tests could include kidney function assessments and imaging studies if needed.

Treatment Protocols: Electrolyte supplements, particularly potassium and magnesium, to correct deficiencies. Medications such as anti-inflammatory drugs (e.g., NSAIDs) to reduce kidney salt loss and improve symptoms. ACE inhibitors or other blood pressure medications might be used in some cases. Adequate hydration to prevent dehydration and electrolyte imbalance. Regular monitoring of blood electrolyte levels and kidney function is essential. In certain cases, ongoing medical supervision is necessary to manage complications and optimize quality of life.